| For: | Zhao YX, Zhao HP, Zhao MY, Yu Y, Qi X, Wang JH, Lv J. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma. World J Gastroenterol 2024; 30(20): 2638-2656 [PMID: 38855150 DOI: 10.3748/wjg.v30.i20.2638] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i20/2638.htm |
| Number | Citing Articles |
| 1 |
Yuan Tian, Xiuzhi Lin. Network pharmacology and molecular docking reveal the therapeutic mechanism of Hedyotis diffusa in esophageal squamous cell carcinoma: A bioinformatics analysis. Medicine 2026; 105(15) doi: 10.1097/MD.0000000000048286
|
| 2 |
Yongbo Yang, Xing Xing, Zhen Qin, Chunyang Han, He Zhu. Alcohol Consumption and Age-Specific Risk of Esophageal Cancer: Prospective Cohort Study. JMIR Public Health and Surveillance 2026; 12 doi: 10.2196/92949
|
| 3 |
Erica Cataldi-Stagetti, Giulia Governatori, Arianna Orsini, Bianca De Nicolo, Rocco Maurizio Zagari, Elena Bonora. MicroRNAs in Esophageal Cancer: Implications for Diagnosis, Progression, Prognosis and Chemoresistance. International Journal of Molecular Sciences 2026; 27(2) doi: 10.3390/ijms27020878
|
| 4 |
Rao Wang, Wei-Guang Liu. Global burden of esophagus cancer, stomach cancer and colon and rectal cancer from 1990 to 2050. Medicine 2026; 105(34) doi: 10.1097/MD.0000000000050376
|
| 5 |
Yanqing Gao, Shuguang Bao, Bao Wen, Haoyuan Li, Qiang Guo, Ao Li, Luri Bao, Meitao Li, Bateer Han. Integration of scRNA-seq and bulk tissue RNA-seq data to identify cancer-associated fibroblast-related gene RGMA as a potential treatment target for esophageal cancer. Functional & Integrative Genomics 2025; 25(1) doi: 10.1007/s10142-025-01660-8
|
| 6 |
Qi-Wei Liu, Zi-Qin Liu, Ming Wang, Yi-Jun Qi. MicroRNAs in esophageal squamous cell carcinoma. Epigenomics 2026; 18(2) doi: 10.1080/17501911.2026.2624361
|
| 7 |
Gangfeng Ding, Jiayao He, Yichao Chen, Lei Liu, Qiaqia He, Lili Li. Heterogeneous nuclear ribonucleoprotein C deficiency compromises extracellular matrix-receptor interaction and induces apoptosis in esophageal cancer by targeting transcripts with complex structures. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2026; 1872(6) doi: 10.1016/j.bbadis.2026.168267
|
| 8 |
Yuxuan Xing, Siao Chen, Kang Hu, Zihan Cui, Yuhan Shao, Jingfeng Zhu, Zhimeng Chen, Jun Chen, Weijun Deng, Cheng Ding, Jun Zhao. Antitumor Effects of Broadleaf Vetch Against Esophageal Squamous Cell Carcinoma Through Dual Mechanisms: Suppressing EMT and Inducing Ferroptosis with Predicted Hepatorenal Toxicity—An Integrative Network Pharmacology and Toxicology Study. Cancers 2026; 18(3) doi: 10.3390/cancers18030370
|
| 9 |
Liang Hong, Jianjian Qiu, Yuling Ye, Yilin Yu, Zhiping Wang, Mingqiu Chen, Wei Zhang. Development of a risk-stratified follow-up strategy based on early and late recurrence risk factors in locally advanced esophageal squamous cell carcinoma after definitive chemoradiotherapy. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1903732
|
| 10 |
Yani Su, Ming Zhang, Qiong Zhang, Pengfei Wen, Ke Xu, Jiale Xie, Xianjie Wan, Lin Liu, Peng Xu, Zhi Yang, Mingyi Yang. Development and validation of a novel signature to predict the survival and affect the immune microenvironment of esophageal squamous cell carcinoma: epigenetic-related genes. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1670600
|
| 11 |
Wen-Jing Wang, Pei Li, Zhi-Qiang Ling. Biomarker-targeted therapies for advanced-stage esophageal cancer. Heliyon 2026; 12(11) doi: 10.1016/j.heliyon.2026.e45079
|
| 12 |
Calin Vaida, Daniel Horvath, Ionut Zima, Marius Miclaus, Bogdan Gherman, Corina Radu, Paul Tucan, Stefan Vegh, Dragos Sebeni, Adrian Pisla, Damien Chablat, Nadim Al Hajjar, Doina Pisla. Modeling and Design of a Spherical Remote Center-of-Motion Surgical Robot. Technologies 2026; 14(7) doi: 10.3390/technologies14070440
|
| 13 |
Chenyang Wang, Yichen Sun, Wanli Yang, Liu Hong, Yabo Zhao. Identification of Small Extracellular Vesicle (sEV)-Related Genes and the Establishment of Diagnostic Models for Esophageal Cancer. Current Medicinal Chemistry 2026; 33(15) doi: 10.2174/0109298673417838251209055114
|
| 14 |
Yibang Ye, Liangyu Zhang, Zhenyuan Yang, Yizhou Huang, Maohui Chen, Shuliang Zhang, Taidui Zeng, Chun Chen, Bin Zheng. Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1825905
|
| 15 |
Fangyu Chen, Ziqi Ye, Yuan Fang, Lei Zhou, Qiuyi Zheng, Yuqi Meng, Lili Wu, Bei Lv, Ping Yang. VPS4A activates glycolytic metabolism via MYO1C to promote radioresistance in ESCC. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-03875-2
|
| 16 |
Lu Yang, Ning Yao, Liting Zhou, Ran Zhou, Jiutao Wang, Ran Yang, Yanle Fan, Wenna Nie, Kangdong Liu, Wei Jiang, Dong Joon Kim, Zigang Dong, Xiang Li. SLC30A7 phosphorylation by ERK1 promotes esophageal squamous cell carcinoma tumorigenesis via activating MMP2/3/9-β-catenin signaling. Cancer Letters 2026; 655 doi: 10.1016/j.canlet.2026.218623
|
| 17 |
Ziyi Bao, Guangtao Zhang, Mijia Shao, Jiyou Chen, Zexing Wei, Chu Zhang, Juan Zhang, Dan Hu, Hongxi Xu, Li Zhang. Gaudichaudione H induces GSDME-mediated pyroptosis and apoptosis in esophageal squamous cell carcinoma via ROS-dependent YAP degradation. Phytomedicine 2026; 160 doi: 10.1016/j.phymed.2026.158677
|
| 18 |
Tingze Feng, Pengfei Li, Siyi Li, Yuhan Wang, Jing Lv, Tian Xia, Hyo-Jong Lee, Hai-Long Piao, Di Chen, Yegang Ma. Metabolic state uncovers prognosis insights of esophageal squamous cell carcinoma patients. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06087-0
|
| 19 |
Parham Pishro, Jalal A. Nasiri, Zahra Nasiri Sarvi, Sara Saeidi, Fatemeh B. Rassouli. Predictive modeling of flavonoid efficacy against esophageal carcinoma: a comprehensive approach. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-23689-2
|
| 20 |
Jie Mao, Kexun Li, Zilong Qian, Jianzhe Zhang, Shengguai Gao, GuoMin Tian, Daiheng Yang, Xin Tang, Xin Yang, Can Li, Yapeng Xing, Jian Xu, Chengwei Bi. Artificial intelligence-assisted endoscopic diagnosis of esophageal squamous cell carcinoma. Frontiers in Artificial Intelligence 2026; 9 doi: 10.3389/frai.2026.1837887
|
| 21 |
Yixuan Lin, Weiping Lin, Chenxu Guo, Xinxin Yang, Hongxue Meng, Liansheng Wang. Medical Image Computing and Computer Assisted Intervention – MICCAI 2025. Lecture Notes in Computer Science 2026; 15965 doi: 10.1007/978-3-032-04978-0_63
|
| 22 |
Liqiang Liu, Wanshi Duan, Tao She, Shouzheng Ma, Haihui Wang, Jiakuan Chen. Machine learning-enabled prediction of bone metastasis in esophageal cancer. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1620687
|
| 23 |
Yucheng Xiang, Lingling Xu, Zhongxiao Lin, Minxia Zhu, Zhifeng He. USP4‐Deubiquitinated PGAM5 Regulates Mitochondrial Dynamics in the Progression of Esophageal Squamous Cell Carcinoma. Molecular Carcinogenesis 2026; 65(1) doi: 10.1002/mc.70055
|
| 24 |
Atsushi Hirata, Koichi Hayano, Toru Tochigi, Yoshihiro Kurata, Tadashi Shiraishi, Nobufumi Sekino, Akira Nakano, Yasunori Matsumoto, Takeshi Toyozumi, Masaya Uesato, Gaku Ohira. Predicting pathological complete response to chemoradiotherapy using artificial intelligence-based magnetic resonance imaging radiomics in esophageal squamous cell carcinoma. World Journal of Gastroenterology 2025; 31(36): 111293 doi: 10.3748/wjg.v31.i36.111293
|
| 25 |
V.V. Tsukanov, Ju.L. Tonkikh, A.V. Vasyutin. Esophageal cancer morbidity, risk factors and screening. Russian Journal of Preventive Medicine 2026; 29(1) doi: 10.17116/profmed202629011110
|
| 26 |
Jingyu Liu, Chenlu Dai, Li Liu, Min Ji, Gulirena Mijiti, Mengjie Zhuang, Sensen Zhu, Ming Cheng, Xuanming Liu, Linlin Zhang, Wei Zhang, Liping Su, Hongwei Pu. ASAP3 activates the NF-κB signaling pathway to promote the progression of esophageal squamous cell carcinoma. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-05368-4
|
| 27 |
Zhen Tian, Dongsheng Zhou, Rui Jiang, Bin Zhou. Role of AMIGO2 in cancer progression: Novel insights (Review). Oncology Letters 2024; 28(3) doi: 10.3892/ol.2024.14567
|
| 28 |
Liying Zhao, Mengqiang Luo, Chunmei Qian, Cheng Liu, Yiying Wang, Miaoxin Chen, Wei Cui, Xiaoyu Wang. Curcumin and its nano formulation inhibit proliferation and FGF21 expression in esophageal squamous cell carcinoma. Biochemical and Biophysical Research Communications 2026; 823 doi: 10.1016/j.bbrc.2026.153905
|
| 29 |
Wei Wei, Xiao-Lei Zhang, Hong-Zhen Wang, Lin-Lin Wang, Jing-Li Wen, Xin Han, Qian Liu. Application of deep learning models in the pathological classification and staging of esophageal cancer: A focus on Wave-Vision Transformer. World Journal of Gastroenterology 2025; 31(19): 104897 doi: 10.3748/wjg.v31.i19.104897
Abstract(436) |
Core Tip(403) |
Full Article(HTML)(1734)
|
Full Article (PDF)-6735K(208)
|
Full Article with Cover (PDF)-7051K(195)
|
Full Article (XML)-165K(109)
|
Audio-1470K(26)
|
Peer-Review Report-270K(141)
|
Answering Reviewers-154K(115)
|
Supplementary Material-1014K(100)
|
Times Cited (4)
|
Total Visits (2887)
|
Open
|
| 30 |
Lucas de Jesus Lima, Matheus Lohan-Codeço, Maria Luísa Barambo Wagner, Isabella Paiva Ramos de Oliveira, Arthur Renato Macedo Adade, Luiz Marcelo Ribeiro Tomé, Nathalia Meireles Da Costa, Luís Felipe Ribeiro Pinto, Luiz Eurico Nasciutti, Mariana Severo Ramundo, Antonio Palumbo. Inhibition of the AT-Hook DNA-Binding Domain Attenuates HMGA2-Mediated Epithelial Mesenchyme Transition in Esophageal Cancer Cells. International Journal of Molecular Sciences 2026; 27(15) doi: 10.3390/ijms27156933
|
| 31 |
Fei Xie, Mobei Zhang, Chunhong Zheng, Zhenwei Zhao, Jiarou Wang, Yufan Li, Kai Wang, Wenzhuo Wang, JunJie Lin, Tingting Wu, Yifan Wang, Xi Chen, Yongchao Li, Zhaohui Zhu, Hubing Wu, Yinfeng Li, Qingxing Liu. Deep learning-based non-invasive prediction of PD-L1 status and immunotherapy survival stratification in esophageal cancer using [18F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 2026; 53(2) doi: 10.1007/s00259-025-07463-0
|
| 32 |
Shilian Pang, Yurao Chen, Zemao Zheng, Luoshai Wang, Ronghuai Chen, Ming He, Xiang Zhao, Juan Yao, Liyan Jin. STAT3-orchestrated gene expression signatures and tumor microenvironment in esophageal squamous cell carcinoma uncovered by single-cell sequencing. Biochimica et Biophysica Acta (BBA) - General Subjects 2025; 1869(6) doi: 10.1016/j.bbagen.2025.130791
|
| 33 |
Xuezhong Shi, Wenjing Xu, Yanpeng Wu, Yongli Yang, Nana Wang, Xiaocan Jia. Heterogeneity in Postoperative Survival Benefit Associated With Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma: A Causal Survival Forest Analysis. International Journal of Cancer 2026; doi: 10.1002/ijc.70729
|
| 34 |
Xiaoyan Men, Yanfeng Wang, Yan Zhao, Huitao Zhang, Xiao Zhang. Endoscopy-Based Deep Learning Algorithms vs Endoscopists in Early Esophageal Squamous Cell Carcinoma Detection: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 2026; doi: 10.14309/ajg.0000000000004067
|
| 35 |
Sergey Tkachev, Vladimir Brosalov, Oleg Kit, Alexey Maksimov, Anna Goncharova, Evgeniy Sadyrin, Alexandra Dalina, Elena Popova, Anton Osipenko, Mark Voloshin, Nikolay Karnaukhov, Peter Timashev. Unveiling Another Dimension: Advanced Visualization of Cancer Invasion and Metastasis via Micro-CT Imaging. Cancers 2025; 17(7) doi: 10.3390/cancers17071139
|
| 36 |
Hui Wang, Jun Li, Yinghai Wang, Yuebin Shi, Peiren Tang, Ying Li, Jiang Gu, Li Wang. Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1832782
|
| 37 |
迎华 程. Research Progress of CD47-SIRP<i>α</i> in Esophageal Cancer. Advances in Clinical Medicine 2025; 15(04) doi: 10.12677/acm.2025.154951
|
| 38 |
Juan Wang, Ji Sun, Chen Liang, Haibin Ou, Jiong Liu, Aoqing Ye, Qiuji Wu, Yu Liu. Identification of potential drug targets and possible drugs for esophageal carcinoma from genetic insights: a comprehensive two-sample Mendelian randomization study. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02777-9
|
| 39 |
Tianhang Zhang, Xiao Chen, Jianhua Wu, Jiasong Li, Zhukun Qin, Ruijie Cao, Wei Guo, Zhanjun Guo, Haiyan Fan. Impact of immune-related adverse events on treatment outcomes in advanced esophageal squamous cell carcinoma treated with immune checkpoint inhibitors. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1741482
|
| 40 |
Chengwen Luo, Zhilin Luo. Case report: Innovative approach to esophageal cancer with right aortic arch: neoadjuvant immunotherapy and 3D reconstruction. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1496265
|
| 41 |
Qingqing Lu, Lian Li, Wenyan Liang, Guoning Xu, Jing Zhu, Xiaobo Ma, Weilu Tian, Lele Gao, Mengyin Tian, Zhongjian Chen, Hengchang Zang. Rapid screening of esophageal squamous cell carcinoma by near-infrared spectroscopy combined with aquaphotomics. Talanta 2025; 285 doi: 10.1016/j.talanta.2024.127399
|
| 42 |
Lijuan Duan, Shasha Cao, Fang Zhao, Xianjuan Du, Zhaowei Gao, Xiaoxiao Wang, Fang Bian. Effects of FAP+ fibroblasts on cell proliferation migration and immunoregulation of esophageal squamous carcinoma cells through the CXCL12/CXCR4 axis. Molecular and Cellular Biochemistry 2025; 480(6) doi: 10.1007/s11010-025-05226-x
|
| 43 |
Ming-Xin Tang, Jin-Feng Chen, Fa-Zhi Zhao, Jun Peng. Ferroptosis: A critical link to treatment resistance in esophageal carcinoma. iScience 2025; 28(7) doi: 10.1016/j.isci.2025.112901
|
| 44 |
Linjia Peng, Zixuan Gao, Yanfeng Liang, Xiaonan Guo, Qiuli Zhang, Daxiang Cui. Nanoparticle-based drug delivery systems: opportunities and challenges in the treatment of esophageal squamous cell carcinoma (ESCC). Nanoscale 2025; 17(14) doi: 10.1039/D4NR05114A
|
| 45 |
Xiangwen Cheng, Ying Liu, Huanyu Chen, Yaqi Pan, Zhe Hu, Zhen Liu, Fangfang Liu, Wenlei Yang, Chuanhai Guo, Lixin Zhang, Liheng Zhang, Fenglei Li, Jiangang Li, Xinna Liu, Haijun Yang, Muyan Cai, Mengfei Liu, Zhonghu He, Yang Ke. γH2AX and p53 Immunohistochemistry predict the incidence risk of esophageal squamous precancerous lesions. BMC Medicine 2026; 24(1) doi: 10.1186/s12916-026-04902-z
|
| 46 |
Rukeyeguli Wusiman, Zhenhong Chang, Feng Yang, Dian Lin, Jiangqi Xu. LMNTD2-AS1 promotes esophageal squamous cell carcinoma progression by sponging miR-449b-5p to upregulate MYCN. World Journal of Surgical Oncology 2026; 24(1) doi: 10.1186/s12957-026-04445-w
|
| 47 |
Takeo Fujita, Kazuma Sato, Daisuke Kajiyama, Yuto Kubo, Naoto Fujiwara, Hiroyuki Daiko. Short-and middle-term outcomes of robot-assisted minimally invasive esophagectomy for highly locally advanced esophageal cancer with stage cT3 borderline and cT4b at initial diagnosis. Surgical Endoscopy 2025; 39(5) doi: 10.1007/s00464-025-11666-9
|
| 48 |
I. Chau, J. Bridgewater, L. Wyrwicz, M. Greenwood, S.I. Blum, A. Moreno-Koehler, E. Martin, F. Taylor, C. Davis, P. Singh. A quality-adjusted time without symptoms and toxicity (Q-TWiST) analysis comparing nivolumab plus ipilimumab or nivolumab plus chemotherapy versus chemotherapy in patients with advanced esophageal squamous-cell carcinoma in CheckMate 648. ESMO Gastrointestinal Oncology 2025; 10 doi: 10.1016/j.esmogo.2025.100235
|
| 49 |
Song Zhang, Chang Su, Zhi-Bo Shen, Jia Huo, Jun-Ping Yang. Outcomes and Safety of PD-1 Blockades Plus Anlotinib Regimen in Previously-Treated Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective, Exploratory Study. Drug Design, Development and Therapy 2026; doi: 10.2147/DDDT.S587621
|
| 50 |
Jiayao Xu, Jiabei Gong, Huiqiong Han, Zehua Wang, Wenjia Wang, Lei Wang, Xin Sui, Guanyu Chen, Yongxu Jia, Yanru Qin. Co-occurrence patterns of esophageal and stomach cancer across 204 countries and territories: a spatial correspondence and systematic analysis. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1613839
|
| 51 |
Jelena Jakab, Anita Matić, Matea Matić Ličanin, Dunja Igrec, Jelena Šakić Radetić, Nikola Volarić, Aleksandar Včev. Biomarkers in Cancer Detection - From Screening to Improving Treatment Outcomes. Oncology 2026; 24 doi: 10.5772/intechopen.1014044
|
| 52 |
Yuan Wang, Li Xin Wan, Yutian Zhang, Qi Jia, Chao Li, Xiaonan Cui. Study on the anticancer mechanism of hydroxygenkwanin in esophageal cancer via the ESRRA signaling pathway. Cancer Genetics 2025; doi: 10.1016/j.cancergen.2025.09.011
|
| 53 |
Yaling Zhang, Tao Sun, Xiaoqi Chen, Dongdong Li, Feifan Feng, Lihan Zhang, Xiaoyu Tang, Jianping Liu, Yuling Zheng. Development and external validation of a nomogram for predicting the risk of developing esophageal cancer based on a questionnaire: a multicenter case-control study. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1684561
|
| 54 |
Lifan Song, Dexu Kong, Zhenxiang Wang, Haoran Wang, Lina Yang. Ubiquitin-specific peptidase 51: A potential target in cancer progression and therapy. Biochemical Pharmacology 2026; 250 doi: 10.1016/j.bcp.2026.117961
|
| 55 |
Ba-Fang Ma, Jun-Nan Ye, Die Bai, Chang Ge, Yingchao Guan, Yang Lou, Ya-Ping Liang, Na Bu, Wenhui Hao, Yasen Maimaitiyiming. Aloperine Suppresses the Tumorigenicity of Esophageal Squamous Cell Carcinoma by Targeting the AP-1/IL-6/STAT3 Signaling Axis. Biomolecules 2026; 16(6) doi: 10.3390/biom16060791
|
| 56 |
Yongzhong Li, Tongtong Li, Jiayi Li, Yirong Su, Yupu Liu, Lihan Chen, Yining Pan, Jiayi Ma, Ting Gong, Huaming Hu. Context-dependent roles of lncRNA JPX in human cancers. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-05419-w
|
| 57 |
Hao Dong, Yang Wang, Peipei Gao, Longqing Yao, Xiaorong Yang, Ziyu Yuan, Tiejun Zhang, Ming Lu, Weimin Ye, Xingdong Chen, Chen Suo. Association of stromal tumor infiltrating lymphocytes and body mass index with prognosis in esophageal squamous cell carcinoma patients. BMC Cancer 2026; 26(1) doi: 10.1186/s12885-026-16045-8
|
| 58 |
Xudong Sun, Dongmei Wu, Guangcheng Ding, Xueying Zhang, Changli Shi, Yulong Tian. Clinical observation of anti-PD-1/PD-L1 immunotherapy plus concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Cytokine 2026; 198 doi: 10.1016/j.cyto.2025.157096
|
| 59 |
Zhan Zhuang, Shaobin Yu, Kaiming Peng, Peipei Zhang, Jingchuan Yu, Jihong Lin, Mingqiang Kang. AI-driven multi-omics drug repurposing nominates AZD7762 as a multitarget inhibitor of IL22RA1 and FAM221A in esophageal squamous cell carcinoma. npj Precision Oncology 2026; 10(1) doi: 10.1038/s41698-026-01485-z
|
| 60 |
Congxue Hu, Xinyu Li, Weixin Liang, Shujuan Li, Xiaozhi Huang, Jing Chen, Kaiyue Yang, Xia Li, Yunpeng Zhang, Jing Bai. Deciphering the Transcription Factor-Dominated Ecosystem During Esophageal Squamous Cell Carcinoma Progression at the Single-Cell Level. International Journal of Molecular Sciences 2026; 27(10) doi: 10.3390/ijms27104433
|
| 61 |
Zhenhua Du, Zhili Jia, Yao Lin, Xudong Zhao, Gengsheng Cao, Hengbin Wang. Chromatin Remodeler RSF1 as an Oncogenic Driver and Therapeutic Target in Esophageal Squamous Cell Carcinoma. Cells 2025; 14(16) doi: 10.3390/cells14161262
|
| 62 |
Guangchun Li, Zhen Zhang, Zhaosheng Chen, Honglei Wu, Jianqiang Guo. Targeting the FOXA2-AGR2 axis overcomes cisplatin resistance in esophageal squamous cell carcinoma through inhibition of endoplasmic reticulum stress. Journal of Radiation Research and Applied Sciences 2026; 19(1) doi: 10.1016/j.jrras.2026.102295
|
| 63 |
Feng Shen, Xing Liu, Fengjiao Ding, Zhonglin Yu, Xinyi Shi, Lushan Cheng, Xuewei Zhang, Chengbao Jing, Zilong Zhao, Hongyou Cao, Bing Zhao, Jing Liu. Integrative bioinformatics analysis of high-throughput sequencing and in vitro functional analysis leads to uncovering key hub genes in esophageal squamous cell carcinoma. Hereditas 2025; 162(1) doi: 10.1186/s41065-025-00398-4
|
| 64 |
Xianghua Zhou, Jiaqi Wang, Fanfan Yang, Yufan Gao, Chunxiao Hou. Functional roles and clinical potential of SOX1 in cancer as a biomarker and therapeutic target. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-04431-4
|